BD-p-tau217

BD-p-tau217 predicts amyloid positivity in humans (AUC 0.95 (95% CI 0.92-0.97)).

Humansdifferentiating amyloid-positive from amyloid-negative individualscerebrospinal fluid

Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs · Molecular neurodegeneration advances · 22 Sep 2026